Clinical trials
Completed Observational Sepsis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
540 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 4 |
| 2005 | 5 |
| 2006 | 10 |
| 2007 | 18 |
| 2008 | 17 |
| 2009 | 28 |
| 2010 | 13 |
| 2011 | 17 |
| 2012 | 25 |
| 2013 | 27 |
| 2014 | 35 |
| 2015 | 24 |
| 2016 | 42 |
| 2017 | 38 |
| 2018 | 33 |
| 2019 | 34 |
| 2020 | 33 |
| 2021 | 29 |
| 2022 | 27 |
| 2023 | 26 |
| 2024 | 29 |
| 2025 | 15 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 540 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ain Shams University | 11 |
| Chinese PLA General Hospital | 10 |
| Beckman Coulter, Inc. | 8 |
| Tanta University | 7 |
| The Cleveland Clinic | 6 |
| University Hospital, Basel, Switzerland | 6 |
| University of Oxford | 6 |
| Abionic SA | 5 |
| European Society of Intensive Care Medicine | 5 |
| Mayo Clinic | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sepsis | 540 |
| Shock, Septic | 102 |
| Infections | 53 |
| Critical Illness | 31 |
| Systemic Inflammatory Response Syndrome | 29 |
| Acute Kidney Injury | 25 |
| Bacteremia | 25 |
| Disease | 22 |
| Emergencies | 20 |
| Pneumonia | 19 |
Trials
Showing 1 to 25 of 540. Each trial links to its page on Pharma Observatory.
440 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.